Hepatic steatosis is a key histological feature of nonalcoholic fatty liver disease (NAFLD).
The non-invasive quantification of liver fat is now possible due to advances in imaging …

Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease
worldwide, with an estimated prevalence of up to 30% in the general population and higher …

New ultrasound methods that can be used to quantitatively assess liver fat content have
recently been developed. These quantitative ultrasound (QUS) methods are based on the …

Quantitative ultrasound (QUS) aims at quantifying interactions between ultrasound and
biological tissues. QUS techniques extract fundamental physical properties of tissues based …

In the world, nonalcoholic fatty liver disease (NAFLD) accounts for majority of diffuse hepatic
diseases. Notably, substantial liver fat accumulation can trigger and accelerate hepatic …

In recent years, ultrasound attenuation imaging (ATI) has emerged as a new method to
detect liver steatosis. However, thus far, no studies have confirmed the clinical utility of this …

Abstract Background and Aim SmartExam is a novel computational method compatible with
FibroScan that uses a software called SmartDepth and continuous controlled attenuation …

Visceral adipose tissue plays a central role in obesity and metabolic syndrome and is an
independent risk factor for both cardiovascular and metabolic disorders. Increased visceral …

The prevalence of the non-alcoholic fatty liver disease has reached major proportions, being
estimated to affect one-quarter of the global population. The reference techniques, which …

The quantification of liver fat as a diagnostic assessment of steatosis remains an important
priority for non-invasive imaging systems. We derive a framework in which the unknown fat …